The US Food and Drug Administration’s top vaccine official overrode agency experts in May to recommend against the broad use ...

Federal documents show he disagreed with conclusions the benefits outweighed the risk of side effects, which are rare.

FDA vaccine head Vinay Prasad restricted Moderna and Novavax COVID vaccines to high-risk groups, overriding staff advice amid ...

The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally ...

A new COVID-19 variant named "Nimbus" has been detected in the U.S. and is spreading rapidly. Here's what to know about ...

The new Nimbus COVID‑19 variant is on the rise and is known for its startling sore‑throat symptom dubbed “razor blade throat.

Recent vaccination announcements have led to some confusion. Four physicians weigh in on who should get vaccinated and when ...

‘Why such sudden deaths are reported more now could have other causes that are not related to health,’ an AIIMS Delhi ...

Investigators concluded that individuals with comorbidities experienced higher risks of severe COVID-19 outcomes during the ...

In patients with COVID-19, preexisting immunity and Omicron infection were associated with reduced disease severity and upper respiratory symptom presentation.

There was a decline in hospitalizations and in-hospital mortality due to COVID-19 between 2023 and 2024, a period spanning the XBB, JN.1, and KP eras.

Cases of the recently identified Covid-19 variant NB 1.8.1. are rising. Some have dubbed the variant "razor blade throat" for ...